Insider · CIK 1245377
Jeffrey J Brown
- Director at Upbound Group UPBD: 37 buys, 0 sales
- Director at Medifast MED: 45 buys, 3 sales
- Director at Cadiz CDZI: 0 buys, 0 sales
- Director at Company with CIK 941604: 0 buys, 0 sales
- Director at Company with CIK 1568832: 1 buys, 0 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys83
Open-market sales3
Bought$7.3M
Sold$3.5M
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | Upbound Group UPBD | Bought 17,645 sh at $22.67 One of 6 insiders who bought $1.3M over 8 days, within the 30-day window. 3 days after the company's 10-Q filed Oct 30, 2026. | $400K | 116,543 +18% | One of 6 insiders who bought $1.3M over 8 days, within the 30-day window. 3 days after the company's 10-Q filed Oct 30, 2026. |
| Oct 27, 2026 | Upbound Group UPBD | Bought 2,764 sh at $17.01 One of 6 insiders who bought $1.3M over 8 days, within the 30-day window. 19 days after the company's SCHEDULE 13G filed Oct 8, 2026. | $47K | One of 6 insiders who bought $1.3M over 8 days, within the 30-day window. 19 days after the company's SCHEDULE 13G filed Oct 8, 2026. | |
| Jul 7, 2026 | Upbound Group UPBD | Bought 2,295 sh at $20.09 15 days after the company's 11-K filed Jun 22, 2026. | $46K | 15 days after the company's 11-K filed Jun 22, 2026. | |
| Apr 28, 2026 | Upbound Group UPBD | Bought 2,329 sh at $19.41 7 days after the company's ARS filed Apr 21, 2026. | $45K | 7 days after the company's ARS filed Apr 21, 2026. | |
| Jan 6, 2026 | Upbound Group UPBD | Bought 2,502 sh at $17.68 33 days after the company's UPLOAD filed Dec 4, 2025. | $44K | 33 days after the company's UPLOAD filed Dec 4, 2025. | |
| Oct 21, 2025 | Upbound Group UPBD | Bought 1,951 sh at $22.27 4 days after the company's CORRESP filed Oct 17, 2025. | $43K | 4 days after the company's CORRESP filed Oct 17, 2025. | |
| Jul 8, 2025 | Upbound Group UPBD | Bought 1,653 sh at $25.90 35 days after the company's 8-K filed Jun 3, 2025. | $43K | 35 days after the company's 8-K filed Jun 3, 2025. | |
| Jun 25, 2025 | Medifast MED | Award 11,168 sh 57 days after the company's DEFA14A filed Apr 29, 2025. | 29,128 | 57 days after the company's DEFA14A filed Apr 29, 2025. | |
| Jun 25, 2025 | Medifast MED | Award 9,449 sh at $13.39 57 days after the company's DEFA14A filed Apr 29, 2025. | $127K | 38,578 | 57 days after the company's DEFA14A filed Apr 29, 2025. |
| May 6, 2025 | Upbound Group UPBD | Bought 21,730 sh at $23.75 Their first shares, by the holdings the Form 4 states. 75 days after the company's 8-K filed Feb 20, 2025. | $516K | 21,730 | Their first shares, by the holdings the Form 4 states. 75 days after the company's 8-K filed Feb 20, 2025. |
| Apr 22, 2025 | Upbound Group UPBD | Bought 1,694 sh at $19.89 61 days after the company's 8-K filed Feb 20, 2025. | $34K | 88,074 +2% | 61 days after the company's 8-K filed Feb 20, 2025. |
| Jan 7, 2025 | Upbound Group UPBD | Bought 1,146 sh at $29.01 119 days after the company's 8-K filed Sep 10, 2024. | $33K | 86,380 +1% | 119 days after the company's 8-K filed Sep 10, 2024. |
| Oct 22, 2024 | Upbound Group UPBD | Bought 1,065 sh at $29.25 42 days after the company's 8-K filed Sep 10, 2024. | $31K | 85,234 +1% | 42 days after the company's 8-K filed Sep 10, 2024. |
| Jul 9, 2024 | Upbound Group UPBD | Bought 1,031 sh at $29.82 54 days after the company's DEFA14A filed May 16, 2024. | $31K | 84,169 +1% | 54 days after the company's DEFA14A filed May 16, 2024. |
| Jun 20, 2024 | Medifast MED | Award 6,596 sh 311 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | 12,380 | 311 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | |
| Jun 20, 2024 | Medifast MED | Award 5,581 sh at $22.66 311 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $126K | 17,961 | 311 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Apr 22, 2024 | Upbound Group UPBD | Bought 991 sh at $30.68 320 days after the company's S-8 filed Jun 7, 2023. | $30K | 83,138 +1% | 320 days after the company's S-8 filed Jun 7, 2023. |
| Jan 9, 2024 | Upbound Group UPBD | Bought 912 sh at $32.94 216 days after the company's S-8 filed Jun 7, 2023. | $30K | 82,147 +1% | 216 days after the company's S-8 filed Jun 7, 2023. |
| Nov 7, 2023 | Medifast MED | Bought 58 sh at $68.89 85 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $4K | 5,784 +1% | 85 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Nov 3, 2023 | Medifast MED | Bought 97 sh at $70.55 81 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $7K | 4,233 +2% | 81 days after a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Oct 24, 2023 | Upbound Group UPBD | Bought 988 sh at $27.61 139 days after the company's S-8 filed Jun 7, 2023. | $27K | 81,235 +1% | 139 days after the company's S-8 filed Jun 7, 2023. |
| Aug 15, 2023 | Medifast MED | Sold 9,832 sh at $89.79 The filing does not mark this sale as under a Rule 10b5-1 plan. 1 day after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $883K | 13,331 −42% | The filing does not mark this sale as under a Rule 10b5-1 plan. 1 day after a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Aug 15, 2023 | Medifast MED | Sold 13,330 sh at $90.47 The filing does not mark this sale as under a Rule 10b5-1 plan. 1 day after a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $1.2M | 1 −100% | The filing does not mark this sale as under a Rule 10b5-1 plan. 1 day after a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Aug 14, 2023 | Medifast MED | Sold 15,154 sh at $92.60 The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Aug 14, 2023. | $1.4M | 23,163 −40% | The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Aug 14, 2023. |
| Aug 8, 2023 | Medifast MED | Bought 44 sh at $89.42 99 days after the company's DEFA14A filed May 1, 2023. | $4K | 5,725 +1% | 99 days after the company's DEFA14A filed May 1, 2023. |
| Aug 4, 2023 | Medifast MED | Bought 689 sh at $100.03 95 days after the company's DEFA14A filed May 1, 2023. | $69K | 95 days after the company's DEFA14A filed May 1, 2023. | |
| Jul 11, 2023 | Upbound Group UPBD | Bought 877 sh at $30.78 34 days after the company's S-8 filed Jun 7, 2023. | $27K | 80,247 +1% | 34 days after the company's S-8 filed Jun 7, 2023. |
| Jun 15, 2023 | Medifast MED | Award 3,289 sh 45 days after the company's DEFA14A filed May 1, 2023. | 5,681 | 45 days after the company's DEFA14A filed May 1, 2023. | |
| May 9, 2023 | Medifast MED | Bought 15 sh at $87.50 8 days after the company's DEFA14A filed May 1, 2023. | $1K | 2,392 +1% | 8 days after the company's DEFA14A filed May 1, 2023. |
| May 5, 2023 | Medifast MED | Bought 754 sh at $89.74 4 days after the company's DEFA14A filed May 1, 2023. | $68K | 4 days after the company's DEFA14A filed May 1, 2023. | |
| Apr 24, 2023 | Upbound Group UPBD | Bought 1,143 sh at $23.28 | $27K | 79,370 +1% | |
| Feb 7, 2023 | Medifast MED | Bought 11 sh at $114.97 | $1K | 2,377 +<1% | |
| Feb 3, 2023 | Medifast MED | Bought 571 sh at $116.11 | $66K | ||
| Jan 10, 2023 | Upbound Group UPBD | Bought 1,084 sh at $24.20 | $26K | 78,228 +1% | |
| Nov 8, 2022 | Medifast MED | Bought 12 sh at $106.93 | $1K | 2,366 +1% | |
| Nov 4, 2022 | Medifast MED | Bought 561 sh at $105.06 | $59K | 36,499 +2% | |
| Oct 25, 2022 | Upbound Group UPBD | Bought 1,475 sh at $17.45 | $26K | 77,144 +2% | |
| Aug 9, 2022 | Medifast MED | Bought 3,940 sh at $126.54 | $499K | ||
| Aug 8, 2022 | Medifast MED | Award 9 sh at $138.78 | $1K | 2,354 | |
| Aug 4, 2022 | Medifast MED | Bought 399 sh at $146.01 | $58K | 35,938 +1% | |
| Jul 12, 2022 | Upbound Group UPBD | Bought 1,223 sh at $20.69 | $25K | 75,669 +2% | |
| Jun 16, 2022 | Medifast MED | Award 1,580 sh | 2,345 | ||
| May 5, 2022 | Medifast MED | Bought 315 sh at $183.25 | $58K | 35,539 +1% | |
| Apr 22, 2022 | Upbound Group UPBD | Bought 962 sh at $25.98 | $25K | 74,446 +1% | |
| Feb 4, 2022 | Medifast MED | Bought 266 sh at $186.40 | $50K | 35,223 +1% | |
| Jan 13, 2022 | Upbound Group UPBD | Bought 557 sh at $44.48 | $25K | 73,484 +1% | |
| Nov 8, 2021 | Medifast MED | Bought 4,200 sh at $231.89 | $974K | ||
| Nov 8, 2021 | Upbound Group UPBD | Bought 24,330 sh at $43.97 | $1.1M | 72,927 +50% | |
| Oct 19, 2021 | Upbound Group UPBD | Bought 277 sh at $54.16 | $15K | 48,597 +1% | |
| Aug 6, 2021 | Medifast MED | Bought 142 sh at $286.16 | $41K | 30,757 +<1% | |
| Jul 13, 2021 | Upbound Group UPBD | Bought 282 sh at $52.76 | $15K | 48,320 +1% | |
| Jul 7, 2021 | Medifast MED | Gift 1,970 sh | 765 | ||
| Jul 7, 2021 | Medifast MED | Gift 1,970 sh | 30,615 | ||
| Jun 3, 2021 | Medifast MED | Award 765 sh | 2,735 | ||
| May 6, 2021 | Medifast MED | Bought 180 sh at $225.04 | $40K | 28,645 +1% | |
| Apr 22, 2021 | Upbound Group UPBD | Bought 272 sh at $54.38 | $15K | 48,037 +1% | |
| Feb 26, 2021 | Upbound Group UPBD | Bought 26,996 sh at $55.56 | $1.5M | 47,765 +130% | |
| Feb 5, 2021 | Medifast MED | Bought 133 sh at $240.99 | $32K | 28,465 +<1% | |
| Jan 12, 2021 | Upbound Group UPBD | Bought 143 sh at $44.69 | $6K | 20,763 +1% | |
| Nov 6, 2020 | Medifast MED | Bought 198 sh at $160.38 | $32K | 28,333 +1% | |
| Oct 26, 2020 | Upbound Group UPBD | Bought 188 sh at $31.50 | $6K | 20,624 +1% | |
| Aug 4, 2020 | Medifast MED | Bought 175 sh at $172.08 | $30K | 28,134 +1% | |
| Jul 28, 2020 | Upbound Group UPBD | Bought 211 sh at $27.74 | $6K | 20,436 +1% | |
| Jul 9, 2020 | Medifast MED | Gift 1,327 sh | 1,970 | ||
| Jul 9, 2020 | Medifast MED | Gift 1,327 sh | 27,960 | ||
| Jun 16, 2020 | Medifast MED | Award 1,970 sh | 3,297 | ||
| Jun 1, 2020 | Upbound Group UPBD | Other 225 sh at $25.79 | $6K | 20,225 | |
| May 8, 2020 | Upbound Group UPBD | Bought 20,000 sh at $23.01 Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. | $460K | 20,000 | Their first shares, by the holdings the Form 4 states. Their first open-market buy here in SEC Tracker's records. |
| May 6, 2020 | Medifast MED | Bought 409 sh at $72.42 | $30K | 26,633 +2% | |
| Feb 5, 2020 | Medifast MED | Gift 15,635 sh | 1,327 | ||
| Feb 5, 2020 | Medifast MED | Gift 15,635 sh | 26,223 | ||
| Feb 4, 2020 | Medifast MED | Bought 116 sh at $101.93 | $12K | 10,588 +1% | |
| Jan 2, 2020 | Cadiz CDZI | Award 1,133 sh at $11.04 241 days after the company's 8-K filed May 6, 2019. | $13K | 8,868 | 241 days after the company's 8-K filed May 6, 2019. |
| Nov 5, 2019 | Medifast MED | Bought 69 sh at $112.31 | $8K | 10,472 +1% | |
| Oct 1, 2019 | Cadiz CDZI | Award 1,017 sh at $12.29 148 days after the company's 8-K filed May 6, 2019. | $12K | 7,735 | 148 days after the company's 8-K filed May 6, 2019. |
| Sep 17, 2019 | Cadiz CDZI | Award 1,086 sh at $11.51 134 days after the company's 8-K filed May 6, 2019. | $12K | 6,718 | 134 days after the company's 8-K filed May 6, 2019. |
| Aug 5, 2019 | Medifast MED | Bought 78 sh at $98.94 | $8K | 10,403 +1% | |
| Jun 30, 2019 | Cadiz CDZI | Award 1,914 sh at $10.45 55 days after the company's 8-K filed May 6, 2019. | $20K | 5,632 | 55 days after the company's 8-K filed May 6, 2019. |
| May 3, 2019 | Medifast MED | Bought 51 sh at $150.06 | $8K | 10,325 +<1% | |
| Apr 1, 2019 | Cadiz CDZI | Award 783 sh at $9.57 | $7K | 3,718 | |
| Feb 22, 2019 | Medifast MED | Award 1,327 sh | 26,962 | ||
| Feb 7, 2019 | Medifast MED | Option exercise 1,667 sh at $27.68 | $46K | 25,635 | |
| Feb 5, 2019 | Medifast MED | Bought 59 sh at $129.49 | $8K | 10,273 +1% | |
| Jan 2, 2019 | Cadiz CDZI | Award 728 sh at $10.30 | $7K | 2,935 | |
| Nov 29, 2018 | Medifast MED | Option exercise 2,500 sh at $28.59 | $71K | 20,635 | |
| Nov 29, 2018 | Medifast MED | Option exercise 3,333 sh at $27.68 | $92K | 23,968 | |
| Nov 8, 2018 | Medifast MED | Bought 30 sh at $157.00 | $5K | 10,214 +<1% | |
| Oct 3, 2018 | Cadiz CDZI | Award 676 sh at $11.10 | $8K | 2,207 | |
| Aug 8, 2018 | Medifast MED | Bought 24 sh at $199.53 | $5K | 10,184 +<1% | |
| Jul 1, 2018 | Cadiz CDZI | Award 574 sh at $13.08 | $8K | 1,531 | |
| Jun 30, 2018 | Cadiz CDZI | Award 393 sh at $12.71 | $5K | 957 | |
| Jun 13, 2018 | Cadiz CDZI | Award 564 sh at $13.30 | $8K | 564 | |
| May 8, 2018 | Medifast MED | Bought 42 sh at $116.43 | $5K | 10,159 +<1% | |
| Feb 8, 2018 | Medifast MED | Bought 72 sh at $66.91 | $5K | 10,118 +1% | |
| Feb 7, 2018 | Medifast MED | Award 1,860 sh | 18,135 | ||
| Nov 9, 2017 | Medifast MED | Bought 45 sh at $70.35 | $3K | 10,045 +<1% | |
| Feb 16, 2017 | Medifast MED | Award 3,021 sh | 16,275 | ||
| Nov 9, 2016 | Medifast MED | Bought 10,000 sh at $38.71 Their first shares, by the holdings the Form 4 states. | $387K | 10,000 | Their first shares, by the holdings the Form 4 states. |
| Nov 9, 2016 | Medifast MED | Bought 10,000 sh at $38.71 Their first open-market buy here in SEC Tracker's records. | $387K | 13,254 +307% | Their first open-market buy here in SEC Tracker's records. |
| Sep 27, 2016 | Company with CIK 941604 | Other 2,601 sh at $52.00 | $135K | 0 | |
| Sep 23, 2016 | Company with CIK 941604 | Other 234 sh at $52.00 | $12K | 2,601 | |
| Jul 7, 2016 | Company with CIK 941604 | Award 2,601 sh | 2,835 | ||
| Apr 11, 2016 | Company with CIK 941604 | Award 234 sh | 234 | ||
| Feb 4, 2016 | Medifast MED | Award 2,579 sh | 3,254 | ||
| Dec 18, 2015 | Company with CIK 1568832 | Returned to company 3,791 sh at $11.21 | $42K | 23,346 | |
| Sep 15, 2015 | Medifast MED | Award 675 sh | 675 | ||
| Aug 18, 2015 | Company with CIK 1568832 | Award 15,873 sh at $2.52 | $40K | 27,137 | |
| Jan 19, 2015 | Company with CIK 1568832 | Award 3,791 sh at $11.21 | $42K | 11,264 | |
| Jul 2, 2014 | Company with CIK 1568832 | Bought 1,000 sh at $22.49 Their first open-market buy here in SEC Tracker's records. | $22K | 7,473 +15% | Their first open-market buy here in SEC Tracker's records. |
| Jun 9, 2014 | RCS Capital | Award 5,044 sh at $29.74 | $150K | 5,044 | |
| Jun 9, 2014 | RCS Capital | Award 1,429 sh at $29.74 | $42K | 6,473 |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.
Data on this page was fetched . The filing on SEC.gov is the record.